U.S. Court of Appeals for the Ninth Circuit, 2014

Romo v. Teva Pharmaceuticals USA, Inc.

Romo v. Teva Pharmaceuticals USA, Inc.
U.S. Court of Appeals for the Ninth Circuit · Decided February 10, 2014 · Kozinski
742 F.3d 909; 2014 WL 505173 (Federal Reporter, Third Series)

Counsel

James Paul Sizemore, The Sizemore Law Firm PLC, El Segundo, CA, Andrew Nathan Chang, Esner, Chang & Boyer, Walnut Creek, CA, Stuart Bruce Esner, Esner, Chang & Boyer, Pasadena, CA, Elise R. Sanguinetti, Khorrami, LLP, Oakland, CA, Matthew J. Sill, Sill Law Group, Edmond, OK, for Plaintiffs-Appellees., Amy Bridget Alderfer, Esquire, Green-berg Traurig LLP, Los Angeles, CA, Karin Bohmholdt, Greenberg & Traurig LLP, Santa Monica, CA, Lori Gail Cohen, Victoria Davis Lockard, Esquire, Ginger Pigott, Esquire, Greenberg & Traurig LLP, Atlanta, GA, Elliot H. Scherker, Esquire, General, Greenberg Traurig PA, Miami, FL, for Defendant-Appellant.

Romo v. Teva Pharmaceuticals USA, Inc.

Cases that cite this one

3 later published cases cite this decision.

This list shows which later cases cite this one. It does not say how they treated it, and no review of that has been done. Not a substitute for Shepard’s or KeyCite — verify before relying.

Opinion of the Court

ORDER

KOZINSKI, Chief Judge:

Upon the vote of a majority of nonre-cused active judges, it is ordered that these cases be reheard en banc pursuant to Federal Rule of Appellate Procedure 35(a) and Circuit Rule 35-3. The three-judge panel opinion in Romo v. Teva Pharmaceuticals USA, Inc., No. 13-56310, shall not be cited as precedent by or to any court of the Ninth Circuit.

Judge McKEOWN did not participate in the deliberations or vote in this case.

Case-law data current through December 31, 2025. Source: CourtListener bulk data.